Literature DB >> 15232358

Association of the -1438 G/A and 102 T/C polymorphism of the 5-Ht2A receptor gene with irritable bowel syndrome 5-Ht2A gene polymorphism in irritable bowel syndrome.

Cengiz Pata1, Emin Erdal, Kemal Yazc, Handan Camdeviren, Mahmut Ozkaya, Oguz Ulu.   

Abstract

GOALS: The aim of this study is to investigate whether there were any association between the 102 T/C and -1438 G/A polymorphisms of the 5-HT2A receptor gene and IBS, and abdominal pain, anxiety and depression.
BACKGROUND: Genes involved in serotonin (5-HT) metabolism are good candidates for the pathogenesis of irritable bowel syndrome (IBS). Recently, a silent polymorphism in the 5-HT2A receptor gene was identified that is defined by a T to C transition at position 102. Also, a novel G to A base change at position -1438 of the promoter region has been detected in 5-HT2A receptor gene. STUDY: Fifty-four patients with IBS diagnosed according to the Rome 1 criteria and 107 healthy individuals were included in the study. PCR was used to amplify a 468-bp (G-->A) and 342-bp (T-->C) fragment of genomic DNA containing the polymorphism. Hospital anxiety and depression scale was used to assess the risk of depression and anxiety. Severity of chronic abdominal pain was determined by visual analogue scale (VAS).
RESULTS: It was shown that there was a high incidence of homozygote C allele of the 102T/C polymorphism (%22.2; OR: 7.89, P = 0.04) and homozygote A allele of the -1438 G/A promoter region (%%37; OR: 11.14, P = 0.01) in patients with IBS. The risk of having an anxiety disorder was 83.3% in patients with C/C genotype, which was higher than other allele carrying patients, and overall mean (%52.7). (chi = 8.56, P = 0.014). The patients with T/T genotype had a VAS score of 54.93 +/- 2.59 mm, which was significantly higher than that of the patients with other genotypes (p1 = 0.02, p2 = 0.001).
CONCLUSION: This study suggests that the patients with homozygote C allele of the 102 T/C polymorphisms or homozygote A allele of the -1438 G/A polymorphism of the 5-HT2A receptor gene, have a high risk of IBS. On the other hand, T/T genotype of 102 T/C polymorphism may be associated with more severe pain in patient with IBS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15232358     DOI: 10.1097/00004836-200408000-00005

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  19 in total

Review 1.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.

Authors:  Michael Camilleri; David A Katzka
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

Review 2.  Genetic approaches to functional gastrointestinal disorders.

Authors:  Yuri A Saito; Nandita Mitra; Emeran A Mayer
Journal:  Gastroenterology       Date:  2010-02-19       Impact factor: 22.682

Review 3.  Genes and environment in irritable bowel syndrome: one step forward.

Authors:  N J Talley
Journal:  Gut       Date:  2006-12       Impact factor: 23.059

Review 4.  Pharmacogenetics and the treatment of functional gastrointestinal disorders.

Authors:  Houssam Halawi; Michael Camilleri
Journal:  Pharmacogenomics       Date:  2017-07-07       Impact factor: 2.533

5.  Trauma history and risk of the irritable bowel syndrome in women veterans.

Authors:  D L White; L S Savas; K Daci; R Elserag; D P Graham; S J Fitzgerald; S L Smith; G Tan; H B El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2010-06-04       Impact factor: 8.171

Review 6.  Genes and irritable bowel syndrome: is there a link?

Authors:  Yuri A Saito
Journal:  Curr Gastroenterol Rep       Date:  2008-08

Review 7.  Genetics of irritable bowel syndrome.

Authors:  Yuri A Saito; Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2008-07-05       Impact factor: 10.864

Review 8.  Genetics and irritable bowel syndrome: from genomics to intermediate phenotype and pharmacogenetics.

Authors:  Michael Camilleri
Journal:  Dig Dis Sci       Date:  2009-08-05       Impact factor: 3.199

9.  New paradigm for studying genetic contributions to irritable bowel syndrome.

Authors:  Miranda A L van Tilburg; William E Whitehead
Journal:  Dig Dis Sci       Date:  2012-10       Impact factor: 3.199

Review 10.  Progress in genetic studies of pain and analgesia.

Authors:  Michael L Lacroix-Fralish; Jeffrey S Mogil
Journal:  Annu Rev Pharmacol Toxicol       Date:  2009       Impact factor: 13.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.